Intuitive Surgical ( (ISRG) ) has released its Q4 earnings. Here is a breakdown of the information Intuitive Surgical presented to its investors.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Intuitive Surgical, Inc., based in Sunnyvale, California, is a global leader in minimally invasive care and the pioneer of robotic-assisted surgery, known for its da Vinci surgical systems and Ion endoluminal system, which aim to enhance care delivery through advanced technology.
Intuitive Surgical recently released its fourth-quarter earnings report for 2024, showing significant growth in both revenue and system placements, highlighting the company’s strong market presence in robotic-assisted surgery.
Key financial highlights include a 25% increase in revenue to $2.41 billion compared to the same quarter in 2023. The company placed 493 da Vinci surgical systems, up from 415 in Q4 2023, contributing to an installed base of 9,902 systems globally. Additionally, Intuitive’s GAAP net income rose to $686 million, with non-GAAP net income at $805 million, demonstrating a robust performance in the period.
The company’s financial position remains strong, with $8.83 billion in cash, cash equivalents, and investments, reflecting a healthy cash flow from operations. Looking ahead, Intuitive expects continued growth in da Vinci procedures with a projected increase of 13% to 16% in 2025, alongside strategic investments in operating expenses to support ongoing innovation and market expansion.
Intuitive Surgical’s management anticipates maintaining its leadership in the minimally invasive care sector, focusing on advancing its technology and expanding its market footprint while navigating potential challenges in the global healthcare landscape.
